From likes to lawsuits: Navigating the insurance impact of Social Media Addiction

Litigation Meets Insurance Exposure

Lawsuits accusing social media companies of engineering addictive features—endless scrolling, algorithmic feeds, push notifications—have moved from filing stages to courtroom confrontations. Coordinated in federal multidistrict litigation in California and parallel state proceedings, these cases target Meta (Instagram/Facebook), Google (YouTube), and others for allegedly prioritizing engagement over safety, leading to anxiety, depression, eating disorders, and suicides among young users.

The timeline accelerated sharply in late 2025 and early 2026. Bellwether selections advanced in mid-2025, with the first major trial commencing in Los Angeles County Superior Court in January or February 2026 against remaining defendants after Snap and TikTok settled undisclosed amounts to exit a key case. Mark Zuckerberg testified in February 2026, facing questions on internal documents showing awareness of harms. The federal MDL, which stood at around 1,900 cases by August 2025, climbed past 2,300 by February 2026 as new filings continued.

For the insurance industry, the stakes center on whether these claims trigger commercial general liability (CGL) coverage. Plaintiffs frame harms as 'bodily injury' from defective product design, but carriers contend deliberate addictive features constitute intentional acts, excluding coverage. Disputes have sparked declaratory judgments, with outcomes poised to influence policy wordings for tech and media risks. Reinsurers are also scrutinizing potential overlaps with cyber or D&O policies.

A less-discussed tension lies in the product liability angle: courts have allowed negligence claims to proceed by distinguishing platform design from third-party content (bypassing Section 230 immunity in some rulings), yet proving causation between algorithms and specific harms remains contentious. Critics argue this risks over-regulating innovation or chilling free speech, while proponents point to internal research—leaked emails suggesting companies knew of addiction loops but proceeded for profit—as evidence of recklessness.

If plaintiffs secure favorable verdicts, payouts could reach billions, echoing mass torts like opioids, and prompt stricter underwriting for technology E&O and liability lines worldwide.